IRIS Accounts Production v24.1.0.578 08615652 director 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086156522022-11-30086156522023-11-30086156522022-12-012023-11-30086156522021-11-30086156522021-12-012022-11-30086156522022-11-3008615652ns15:EnglandWales2022-12-012023-11-3008615652ns14:PoundSterling2022-12-012023-11-3008615652ns10:Director12022-12-012023-11-3008615652ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3008615652ns10:SmallEntities2022-12-012023-11-3008615652ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3008615652ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3008615652ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3008615652ns10:FullAccounts2022-12-012023-11-3008615652ns10:EntityHasNeverTraded2022-12-012023-11-3008615652ns10:RegisteredOffice2022-12-012023-11-3008615652ns5:CurrentFinancialInstruments2023-11-3008615652ns5:CurrentFinancialInstruments2022-11-3008615652ns5:Non-currentFinancialInstruments2023-11-3008615652ns5:Non-currentFinancialInstruments2022-11-3008615652ns5:ShareCapital2023-11-3008615652ns5:ShareCapital2022-11-3008615652ns5:RetainedEarningsAccumulatedLosses2023-11-3008615652ns5:RetainedEarningsAccumulatedLosses2022-11-3008615652ns5:FurnitureFittings2022-12-012023-11-3008615652ns5:LongLeaseholdAssetsns5:LandBuildings2022-11-3008615652ns5:FurnitureFittings2022-11-3008615652ns5:LongLeaseholdAssetsns5:LandBuildings2022-12-012023-11-3008615652ns5:LongLeaseholdAssetsns5:LandBuildings2023-11-3008615652ns5:FurnitureFittings2023-11-3008615652ns5:LongLeaseholdAssetsns5:LandBuildings2022-11-3008615652ns5:FurnitureFittings2022-11-3008615652ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3008615652ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-30
REGISTERED NUMBER: 08615652 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2023

FOR

MAURIPHARM (LEATHERHEAD) LTD

MAURIPHARM (LEATHERHEAD) LTD (REGISTERED NUMBER: 08615652)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MAURIPHARM (LEATHERHEAD) LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTOR: A C Kureeman





REGISTERED OFFICE: 224 Barnet Wood Lane
Ashtead
Surrey
KT21 2DB





REGISTERED NUMBER: 08615652 (England and Wales)





ACCOUNTANTS: Romsey Accountants GDT Limited
First Floor Secure House
Lulworth Close
Chandler's Ford
Hampshire
SO53 3TL

MAURIPHARM (LEATHERHEAD) LTD (REGISTERED NUMBER: 08615652)

BALANCE SHEET
30 NOVEMBER 2023

30.11.23 30.11.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,179,524 652,215

CURRENT ASSETS
Stocks 88,196 39,600
Debtors 5 345,542 202,561
Cash at bank and in hand 45,394 119,936
479,132 362,097
CREDITORS
Amounts falling due within one year 6 1,025,161 856,075
NET CURRENT LIABILITIES (546,029 ) (493,978 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

633,495

158,237

CREDITORS
Amounts falling due after more than
one year

7

360,000

-
NET ASSETS 273,495 158,237

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 273,395 158,137
273,495 158,237

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MAURIPHARM (LEATHERHEAD) LTD (REGISTERED NUMBER: 08615652)

BALANCE SHEET - continued
30 NOVEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 September 2024 and were signed by:





A C Kureeman - Director


MAURIPHARM (LEATHERHEAD) LTD (REGISTERED NUMBER: 08615652)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023


1. STATUTORY INFORMATION

Mauripharm (Leatherhead) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

MAURIPHARM (LEATHERHEAD) LTD (REGISTERED NUMBER: 08615652)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2022 - 7 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Long and
leasehold fittings Totals
£    £    £   
COST
At 1 December 2022 650,000 3,461 653,461
Additions 525,803 2,437 528,240
At 30 November 2023 1,175,803 5,898 1,181,701
DEPRECIATION
At 1 December 2022 - 1,246 1,246
Charge for year - 931 931
At 30 November 2023 - 2,177 2,177
NET BOOK VALUE
At 30 November 2023 1,175,803 3,721 1,179,524
At 30 November 2022 650,000 2,215 652,215

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Trade debtors 297,506 191,914
Other debtors 48,036 10,647
345,542 202,561

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Bank loans and overdrafts 26,667 -
Trade creditors 224,851 120,951
Amounts owed to associates 734,606 709,167
Taxation and social security 36,416 23,785
Other creditors 2,621 2,172
1,025,161 856,075

MAURIPHARM (LEATHERHEAD) LTD (REGISTERED NUMBER: 08615652)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.11.23 30.11.22
£    £   
Bank loans 360,000 -

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 253,333 -